Updated
Updated · The New York Times · Aug 15
Oura Sues 7 Rivals Over Patents as $44 Billion Wearables Race Targets Medical Care
Updated
Updated · The New York Times · Aug 15

Oura Sues 7 Rivals Over Patents as $44 Billion Wearables Race Targets Medical Care

1 articles · Updated · The New York Times · Aug 15

Summary

  • Oura has sued seven competitors for patent infringement, winning three cases and leaving four pending, as wearable makers fight for position beyond basic fitness tracking.
  • The legal push reflects a bigger prize: the $44 billion wearables market is trying to become part of the medical ecosystem, where doctors and hospitals could recommend devices for continuous health monitoring.
  • Apple is also caught in that battle, facing at least two patent lawsuits even as Apple Watch ships about 8 million devices in a quarter—more than Oura has sold in total.
  • Partnerships are already moving the sector toward healthcare integration: Apple has teamed with Epic Systems, while Dexcom invested $75 million in Oura in 2024 and paired with the ring maker.

Insights

Will the billion-dollar patent wars over wearable health technology delay life-saving features from reaching your wrist?
As tech giants turn smartwatches into clinical tools, who really owns and controls your most intimate medical data?
Could the push for recurring medical subscriptions turn everyday fitness trackers into mandatory healthcare monitoring devices?